Avi Veidman

Avi is a senior Tech-Bio leader with more than 25 years of experience leading multidisciplinary teams in a Volatile, Uncertain, Complex, and Ambiguous environment. Avi has a proven track record in all aspects of R&D, general management, and fundraising, focusing on strategic planning and partnership building.
He is the co-founder and CEO of Nucleai, a spatial biology platform company transforming drug R&D and clinical treatment decisions powered by AI Pathology.
Avi was a key player in fundraising for the company (Three investment rounds summing up to $50 million from world-leading Tech-Bio investors - Section32 and Sanofi).
Before establishing Nucleai, Avi has over 20 years of experience in technology leadership roles in elite technological units in the Israeli Intelligence forces. During his service, he established an AI-Data science department specializing in computer vision and spatial information analysis. Avi holds an MSc. and BSc. in Geoinformatics (Cum Laude) from the Technion.
He loves to read books, surf waves, and walk in the countryside in his spare time.